OBI Pharma, Inc. (TPEX:4174)
Taiwan · Delayed Price · Currency is TWD 44.05
-1.05 (-2.33%)
Feb 11, 2026, 1:30 PM CST
OBI Pharma Market Cap
OBI Pharma has a market cap or net worth of 5.93 billion as of February 10, 2026. Its market cap has decreased by -61.05% in one year.
Market Cap
5.93B
Enterprise Value
5.78B
Revenue
49.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
44.05
Market Cap Chart
Since December 12, 2012, OBI Pharma's market cap has decreased from 16.87B to 5.93B, a decrease of -64.84%. That is a compound annual growth rate of -7.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 6.19B | -12.87% |
| Dec 31, 2025 | 7.10B | -53.86% |
| Dec 31, 2024 | 15.39B | -3.28% |
| Dec 29, 2023 | 15.91B | 0.50% |
| Dec 30, 2022 | 15.83B | -30.20% |
| Dec 30, 2021 | 22.68B | -13.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adimmune | 7.67B |
| Mycenax Biotech | 6.91B |
| Savior Lifetec | 6.19B |
| Sinphar Pharmaceutical | 5.83B |
| CHO Pharma | 5.69B |
| Locus Cell | 5.51B |
| Pharmosa Biopharm | 5.41B |
| Panion & Bf Biotech | 5.30B |